Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2016 | Dec. 31, 2015 | Mar. 31, 2015 | Dec. 31, 2015 |
Stock-Based Compensation | | | | |
Expense incurred for stock-based compensation plans | $ 11.6 | | $ 10.1 | |
Expense incurred for stock-based compensation plans, net of tax | $ 8.8 | | 7.6 | |
2000 Employee Option Plan | | | | |
Stock-Based Compensation | | | | |
Number of additional stock options that can be granted (in shares) | 0 | | | |
Options exercisable period | 10 years | | | |
2009 Employee Option Plan | | | | |
Stock-Based Compensation | | | | |
Common Stock reserved for issuance | 58,000,000 | | | |
Shares available for the granting of additional stock options | 18,714,960 | | | |
Options exercisable period | 10 years | | | |
Options ratable vesting period | 5 years | | | |
2004 Directors Option Plan | | | | |
Stock-Based Compensation | | | | |
Shares available for the granting of additional stock options | 140,000 | | | |
Options exercisable period | 10 years | | | |
Number of additional stock options expected to be granted (in shares) | 0 | | | |
Stock Options | | | | |
Stock option activity | | | | |
Options outstanding at the beginning of the period (in shares) | 31,136,475 | | | |
Options granted (in shares) | 245,000 | | | |
Options exercised (in shares) | (650,840) | | | |
Options forfeited (in shares) | (48,680) | | | |
Options outstanding at the end of the period (in shares) | 30,681,955 | 31,136,475 | | 31,136,475 |
Vested and non-vested options expected to vest at the end of the period (in shares) | 28,686,910 | | | |
Exercisable at the end of the period (in shares) | 13,206,995 | | | |
Weighted Average Exercise Price | | | | |
Weighted average exercise price, options outstanding at the beginning of the period (in dollars per share) | $ 37.62 | | | |
Weighted average exercise price, options outstanding at the end of the period (in dollars per share) | 37.97 | $ 37.62 | | $ 37.62 |
Weighted average exercise price, vested and non-vested options expected to vest (in dollars per share) | 37.34 | | | |
Weighted average exercise price, exercisable (in dollars per share) | $ 27.03 | | | |
Weighted Average Remaining Contractual Term | | | | |
Weighted average remaining contractual term of options outstanding | 6 years 9 months | | | 6 years 11 months 1 day |
Weighted average remaining contractual term of options vested options and non-vested expected to vest | 6 years 7 months 28 days | | | |
Weighted average remaining contractual term of options exercisable | 5 years 1 month 24 days | | | |
Aggregate Intrinsic Value | | | | |
Aggregate intrinsic value of options outstanding | $ 609.9 | $ 491 | | $ 491 |
Aggregate intrinsic value of options, vested and non-vested options expected to vest | 588.3 | | | |
Aggregate intrinsic value of options exercisable | $ 406.6 | | | |
Status of the Company's non-vested options and changes during the year | | | | |
Non-vested options at the beginning of the period (in shares) | 17,323,040 | | | |
Non-vested options, options granted (in shares) | 245,000 | | | |
Non-vested options, options vested (in shares) | (44,400) | | | |
Non-vested options, options forfeited (in shares) | (48,680) | | | |
Non-vested options at the end of the period (in shares) | 17,474,960 | 17,323,040 | | 17,323,040 |
Weighted Average Fair Value at Grant Date | | | | |
Weighted average fair value at the grant date, options outstanding at the beginning of the period (in dollars per share) | $ 8.24 | | | |
Weighted average fair value at grant date, options granted (in dollars per share) | 6.98 | | | |
Weighted average fair value at grant date, options vested (in dollars per share) | 9.82 | | | |
Weighted average fair value at grant date, options forfeited (in dollars per share) | 8.38 | | | |
Weighted average fair value at the grant date, options outstanding at the end of the period (in dollars per share) | $ 8.22 | $ 8.24 | | $ 8.24 |
Fair Value at Grant Date | | | | |
Total intrinsic value of stock options exercised | $ 20.7 | | 25.9 | |
Total fair value of stock options vested | 0.4 | | $ 0.3 | |
Total compensation cost related to non-vested options not yet recognized | $ 97.4 | | | |
Weighted average expected amortization period | 3 years 2 months 12 days | | | |
Restricted Shares | | | | |
Fair Value at Grant Date | | | | |
Total compensation cost related to non-vested restricted shares not yet recognized | $ 0.1 | | | |
Weighted average expected amortization period | 1 month 24 days | | | |
Restricted Shares | 2012 Directors Restricted Stock Plan | | | | |
Stock-Based Compensation | | | | |
Shares available for the granting of additional stock options | 153,974 | | | |
Restricted share activity | | | | |
Restricted shares outstanding at the beginning of the period (in shares) | 17,256 | | | |
Restricted shares outstanding at the end of the period (in shares) | 17,256 | 17,256 | | 17,256 |
Fair Value at Grant Date | | | | |
Fair value at the grant date, restricted shares outstanding at the beginning of the period (in dollars per share) | $ 57.97 | | | |
Fair value at the grant date, restricted shares outstanding at the end of the period (in dollars per share) | $ 57.97 | $ 57.97 | | $ 57.97 |
Weighted Average Remaining Amortization Term (in years) | 1 month 24 days | 4 months 21 days | | |